Home > Publications database > Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer. > print

001     294115
005     20250523132249.0
024 7 _ |a 10.1002/ctm2.70010
|2 doi
024 7 _ |a pmid:39439221
|2 pmid
037 _ _ |a DKFZ-2024-02120
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wang, Yuan
|0 0009-0007-1943-3286
|b 0
245 _ _ |a Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.
260 _ _ |a Hoboken, NJ
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1729692557_9810
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Lazaridou, Maria-Filothei
|b 1
700 1 _ |a Kordass, Theresa
|0 P:(DE-He78)70e630b77e8ddc41353fc23197569b7c
|b 2
|u dkfz
700 1 _ |a Massa, Chiara
|b 3
700 1 _ |a Vaxevanis, Christoforos K
|0 0000-0003-4765-1719
|b 4
700 1 _ |a Eichmüller, Stefan
|0 P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944
|b 5
|u dkfz
700 1 _ |a Seliger, Barbara
|0 0000-0002-5544-4958
|b 6
773 _ _ |a 10.1002/ctm2.70010
|g Vol. 14, no. 10, p. e70010
|0 PERI:(DE-600)2697013-2
|n 10
|p e70010
|t Clinical and translational medicine
|v 14
|y 2024
|x 2001-1326
856 4 _ |u https://inrepo02.dkfz.de/record/294115/files/Clinical%20Translational%20Med%20-%202024%20-%20Wang%20-%20Unconventional%20microRNA%20role%20Enhancing%20the%20human%20leukocyte%20antigen%20class%20I.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/294115/files/Clinical%20Translational%20Med%20-%202024%20-%20Wang%20-%20Unconventional%20microRNA%20role%20Enhancing%20the%20human%20leukocyte%20antigen%20class%20I.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:294115
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)70e630b77e8ddc41353fc23197569b7c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-06-08T15:16:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-06-08T15:16:46Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2020-06-08T15:16:46Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-06-08T15:16:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-26
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2023-10-26
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-26
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-26
920 1 _ |0 I:(DE-He78)D210-20160331
|k D210
|l GMP-Einheit Zelluläre Therapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D210-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21